Overview Fundamentals API Earnings EOD API Sample Code Pricing

Biodesix Inc (BDSX NASDAQ) stock market data APIs

$1.73 0.01(0.6%) as of July 26, 2024
Price chart is built with Anychart

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Biodesix Inc Financial Data Overview

1.72
1.73
-
1.73
1.675
1.09-2.21
190 M
115 M
54 849 K
-0.14
1.202
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BDSX',
Type: 'Common Stock',
Name: 'Biodesix Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001J2LMV6',
ISIN: NULL,
CUSIP: NULL,
CIK: '1439725',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-10-28',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: NULL,
IsDelisted: false,
}

Biodesix Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 54 849 K
  • EBITDA -31 935 000
  • Earnings Per Share -0.54
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Biodesix Inc Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -0.14

Get Biodesix Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com